The California Institute for Regenerative Medicine was established
In 2005, the California Institute for Regenerative Medicine (CIRM) was formally established following the passage of Proposition 71…
The Center for Drug Discovery was established at the University of Georgia
In 2005, The Center for Drug Discovery was established at the University of Georgia to fulfill a critical…
The Penn Cardiovascular Institute (CVI) was established
In 2005, the Penn Cardiovascular Institute (CVI) was established as a collaborative multi-disciplinary group of basic and translational…
UW Doctor performed SCCA’s first video-assisted thoracic surgery
In 2005, Dr. Michael Mulligan from the University of Washington performed Seattle Cancer Care Alliance’s (SCCA) first video-assisted…
The CDC assisted with the public health response to the devastating tsunami in the Indian Ocean
On Dec. 26, 2004, the U.S. Centers for Disease Control and Prevention (CDC) assisted with an earthquake measuring…
The National Cancer Institute study determined that a new molecular test can predict the risk of breast cancer recurrence
On Dec. 10, 2004, a National Cancer Institute (NCI) supported study determined that a new molecular test done…
TGen and IGC moved into their new state-of-the-art headquarters
In Dec. 2004, TGen and IGC moved into their new state-of-the-art headquarters. The six-story, $46 million building forms…
David H Murdock purchased the former Cannon Mills site at auction, future home of the North Carolina Research Campus
In Dec. 2004, David H. Murdock purchased the former Cannon Mills site at auction, future home of the…
Biotechnology | Disease | FDA | Oncology | Therapeutics
Genentech drug Tarceva (erlotinib) was approved
On Nov. 18, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Genentech’s drug Tarceva…
OHSU was awarded $4 million NIH biodefense contract to study tuberculosis
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Letrozole was approved by the FDA for the adjuvant treatment of early-stage breast cancer after five years of tamoxifen therapy
On Oct. 29, 2004, the U.S. Food and Drug Administration (FDA) approved Letrozole for the extended adjuvant treatment…
UI Microbiology Professor Mark Stinski made the discoveries of CMV promoter and was named Iowa Inventor of the Year
On Sept. 30, 2003, University of Iowa (UI) Microbiology Professor Mark Stinski made the discoveries of CMV promoter…
Pacific Northwest team unveiled the largest virus proteome to date
On Sept. 29, 2004, a team from scientists from the Pacific Northwest National Laboratory and Oregon Health &…
National Institutes of Health opened the Mark O Hatfield Clinical Research Center
On Sept. 22, 2004, the National Institutes of Health (NIH) opened the Mark O. Hatfield Clinical Research Center,…
OHSU announced collaboration with PNNL on biodefense project studying salmonella, pox viruses
On Sept. 14, 2004, researchers at OHSU and OHSU’s Vaccine and Gene Therapy Institute announced a collaboration with…
Biotechnology | Chemical | Diagnostics | FDA | Infectious Disease | Radiology | Therapeutics | U.S. Congress
Project BioShield Act authorized FDA to expedite review procedures for treatments for chemical, biological and nuclear agents
On Jul. 21, 2004, Project BioShield Act of 2004 was signed by President George W. Bush. The Act…
The 8th and final report of the Immunization Safety Review Committee was issued by the Institute of Medicine
On Jun. 26, 2004, the 8th and final report of the Immunization Safety Review Committee was issued by…
The Schnitzer Investment Corporation donated nearly 20 acres of riverfront property in South Waterfront to OHSU
On Jun. 16, 2004, Portland’s Schnitzer Investment Corp. donated nearly 20 acres of land at the South Willamette…
University of Alabama Mecial Center’s new multi-specialty clinic and College of Community Health Sciences opened
On May 11, 2004, the University of Alabama Medical Center’s opened a new $13.5 million 77,000 square foot…
DNA Day commemorates the successful completion of the Human Genome Project and discovery of DNA’s double helix
On April 25 known as DNA Day, is a day that commemorates the successful completion of the Human…
Eli Lilly and Company launched Symbyax in the U.S.
On Apr. 19, 2004, Eli Lilly and Company launched Symbyax in the U.S., the first and only Food…
Biotechnology | Diagnostics | Disease | Environmental | NIH | Non-Profit Research | Oncology | Therapeutics
The National Center for Vermiculite and Asbestos-Related Cancers was established
Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
The Kavli Foundation Institute awarded $7.5 million to establish the Institute of Neuroscience at Yale University
On Mar. 11, 2004, The Kavli Foundation announced a $7.5 million award to establish the Kavli Institute of…
The Kavli Foundation established the Kavli Institute for Brain and Mind at the University of California, San Diego
On Mar. 19, 2004, University of California, San Diego (UCSD) was awarded $7.5 million to establish The Kavli…
The Kavli Foundation Institute awarded $7.5 million to establish the Institute for Brain Science at Columbia University Medical Center
On Mar. 10, 2004, The Kavli Foundation announced a $7.5 million award to establish a Kavli Institute for…
The National incident Management System was established to coordinate response for public health incidents
On Mar. 1, 2004, the National incident Management System (NIMS), developed by the Department of Homeland Security (DHS),…
Biotechnology | FDA | Medicine | Oncology | Therapeutics
FDA approved the first antiangiogenic drug for cancer, Avastin
On Feb. 26, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved the first antiangiogenic…
Biotechnology | FDA | Oncology | Therapeutics
The monoclonal antibody cetuximab (Erbitux) was approved by the FDA for the treatment of metastatic colorectal cancer
On Feb. 1, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Cetuximab, a recombinant…
OHSU School of Medicine’s Casey Eye Institute received $2.6 million to study glaucoma
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved oxaliplatin (Eloxatin) for use in the treatment of advanced colorectal cancer
On Jan. 9, 2004, the Food and Drug Administration (FDA) announced the approval of Sanofi’s Eloxatin (oxaliplatin) injection…